Timeless Capital Corp. News Releases

Timeless Capital Corp. Announces Grant of Options, CEO Transition, and Board Changes

Wed, 23 Apr 2025 19:58:00 -0400

Calgary, Alberta--(Newsfile Corp. - April 23, 2025) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation") announces that the board of directors of the Corporation, has approved the grant of stock options pursuant to its stock option plan (the "Plan") to its directors and officers, to purchase up to an aggregate of 1,150,000 common shares in the capital of the company (the "Options"). The Options are granted on a conditional basis, subject to approval by the shareholders of the...

Timeless Capital Corp. Announces Closing of Private Placement, Certain Changes to Management, and Additional Shares Acquired by Daniel Lanskey

Fri, 15 Nov 2024 16:30:00 -0500

Calgary, Alberta--(Newsfile Corp. - November 15, 2024) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation") is pleased to announce the closing of the private placement announced on October 15, 2024 (the "Private Placement"). The Corporation has closed on aggregate gross proceeds of $25,000 through the issuance of 2,500,000 common shares of the Corporation ("Common Shares") at a purchase price of $0.01 per share. The net proceeds of the Private Placement will be used to fund...

Timeless Capital Corp. Announces Private Placement Financing

Tue, 15 Oct 2024 16:30:00 -0400

Calgary, Alberta--(Newsfile Corp. - October 15, 2024) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation") is pleased to announce a non-brokered private placement financing of common shares ("Common Shares") at a price of C$0.01 per Common Share (the "Offering Price"), for aggregate gross proceeds of up to C$30,000 and a maximum of 3,000,000 Common Shares (the "Private Placement").The Corporation expects to close the Private Placement on or before October 21, 2024 (the...

Timeless Capital Corp. Announces Resumption of Trading

Tue, 31 Oct 2023 10:16:00 -0400

Calgary, Alberta--(Newsfile Corp. - October 31, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation"), a capital pool company listed on the TSX Venture Exchange ("TSXV" or the "Exchange"), is pleased to report that the common shares of the Corporation are expected to resume trading on the Exchange on Thursday, November 2, 2023, following the termination of the amalgamation agreement and related financing/reverse takeover transaction between the Corporation and...

Timeless Capital Corp. Announces Termination of Letter of Intent with Renaissance Bioscience Corp.

Thu, 19 Oct 2023 18:15:00 -0400

Calgary, Alberta--(Newsfile Corp. - October 19, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation"), a capital pool company as defined under TSX Venture Exchange ("TSXV" or the "Exchange") Policy 2.4 - Capital Pool Companies ("Policy 2.4"), wishes to report that the previously announced amalgamation agreement (the "Agreement") between the Corporation and Renaissance Bioscience Corp. ("Renaissance"), dated April 5, 2023, has been terminated by mutual agreement between...

Timeless Capital Corp. and Renaissance Bioscience Corp. Announce Refinancing of Secured Convertible Debentures and Reduction of Minimum Concurrent Financing

Fri, 30 Jun 2023 18:28:00 -0400

Calgary, Alberta--(Newsfile Corp. - June 30, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless") and Renaissance BioScience Corp. ("Renaissance" or the "Company") are pleased to announce the close of the non-brokered refinancing ("Refinancing") of the Company's existing $5,000,000 principal amount of 12% secured convertible debentures maturing on June 30, 2023 ("Existing Debentures"). Pursuant to the Refinancing, the Company issued a first tranche of $5,560,000 principal amount of 15%...

Timeless Capital Corp. and Renaissance Bioscience Corp. Announce Definitive Agreement and TSXV Conditional Approval of Transaction

Mon, 24 Apr 2023 12:52:00 -0400

Calgary, Alberta--(Newsfile Corp. - April 24, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless") and Renaissance BioScience Corp. ("Renaissance") are pleased to announce that they have entered into an amalgamation agreement dated April 5, 2023 (the "Amalgamation Agreement") in connection with their previously announced business combination (the "Transaction") and that shareholders of Renaissance approved the Transaction and related matters at an annual general and special meeting of...

Timeless Capital Corp. and Renaissance Bioscience Corp. Announce Terms of Private Placement in Connection with Qualifying Transaction

Tue, 28 Feb 2023 09:30:00 -0500

Calgary, Alberta--(Newsfile Corp. - February 28, 2023) - Timeless Capital Corp. (TSXV: TLC.P) ("Timeless" or the "Corporation") and Renaissance BioScience Corp. ("Renaissance") are pleased to announce the proposed terms of a brokered private placement targeting gross proceeds of a minimum of $3,600,000 and up to $5,000,000 of units of Renaissance ("Units"), with the ability to increase the offering to such amount as may be agreed to by Renaissance and the Lead Agent, to be completed in...